Optimization of dose and technique for Magnetic Resonance studies with an oral contrast agent;Ottimizzazione della dose e della tecnica di esame nell'utilizzazione di un mezzo di contrasto orale nella Risonanza Magnetica

Radiologia Medica

Volumn 97, Issue 5, 1999, Pages 365-370

  Broglia, Laura ^a,b   Tortora, Alessandra ^a   Maccioni, Francesca ^a   Arpesani, Roberto ^a   Marcelli, Giulia ^a   Ascarelli, Alessandra ^a   Rossi, Plinio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

Gastrointestinal tract; MRI MRI; Oral contrast agent

Indexed keywords

FERRIC AMMONIUM CITRATE; FERRISELTZ; UNCLASSIFIED DRUG;

ARTICLE; CONTRAST ENHANCEMENT; DOSE RESPONSE; DRUG UPTAKE; HUMAN; IMAGE ENHANCEMENT; IMAGE PROCESSING; NUCLEAR MAGNETIC RESONANCE IMAGING; SIGNAL PROCESSING;

ADMINISTRATION, ORAL; CONTRAST MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0032772936     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ehman RL, Kjos BO, Hricak H e Coll: Relative intensity of the abdominal organs in MR images. JCAT 9: 315-319, 1985.
2. Finazzo M, Midiri M, Gallo C e Coll: Studio delle lesioni focali epatiche. Confronlo tra Risonanza Magnetica in condizioni di base e dopo mdc superparamagnetico. Radiol Med 6: 599-607, 1998.
3. Giovagnoni A, Paci K, Valeri G e Coll: Fegato: RM tradizionale. Radiol Med 91 (Suppl 1 al n. 5) 122-129, 1996.
4. Hahn PF, Stark DD, Lewis JM e Coll: First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR Imaging. Radiology 175: 695-700, 1990.
5. Hiraishi K, Narahayashi I, Fujita O e Coll: Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR Imaging. Radiology 194: 119-123, 1995.
6. Hirohashi S, Hirohashi R, Uchida H e Coll: MR Cholangiopancreatography and MR Urography: improved enhancement with a negative oral contrast agent. Radiology 203: 281-285, 1997.
7. Hirohashi S, Uchida H, Yoshikawa K e Coll: Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn Res Imaging 6: 837-846, 1994.
8. Kaminsky S, Laniado M, Gogoll M e Coll: Gadopentate dimeglumine as a bowel contrast agent: safety and efficacy. Radiology 178: 503-508, 1991.
9. Laniado M, Kornmesser W, Hamm B e Coll: MR imaging of the gastrointestinal tract: value of Gd-DTPA. AJR 150: 817-821, 1998.
10. Manfredi R, Maresca G, Tartaglione T e Coll: Sequenze T2 dipendenti nello studio delle lesioni focali epatiche: comparazione delle sequenze spin eco tradizionali e fast spin eco a 0,5 T. Radiol Med 92: 236-240, 1996.
11. Mattrey RF, Hajek PC, Gylys-Morin VM e Coll: Perfluorochemicals as contrast agent for resonance imaging: preliminary study in rats and humans. AJR 148: 1259-1263, 1987.
12. Shiga Y, Kawamura Y, Iwasakyi Y e Coll: Review on the diagnostic capacity of upper abdominal MRI using an oral contrast agent containing ferric ammonium citrate. Jap MR Med J 11: 182-188, 1991.
13. Tervahartiala P, Kivisaari L, Lamminen e Coll: Dynamic fast-gradient echo MR imaging of pancreatic tumours. Eur J Rad 25: 74-80, 1997.
14. Togami I. Joja I, Mitsurnori A e Coll: MRI diagnosis of gastric cancer using an oral contrast agent containing ferric ammonium citrate. Diagnostic Imaging 12: 580-588, 1992.
15. Paley MR, Ros PR. MRI of the gastrointestinal tract. Eur Radiol 7: 1387-1397, 1997.
16. Young IR, Clark GJ, Bailes DR e Coll: Enhancement of relaxation rate with paramagnetic contrast agent in MR imaging. CT 5: 543-546, 1981.
17. Weinreb GC, Maravillia KR, Redman HC e Coll: Improve of the MR Imaging of the upper abdomen with glucagon and gas. JCAT 8: 835-838, 1984.
18. Wesbey GE, Brash RC, Goldberg HI e Coll: Diluted oral iron solution as gastrointestinal contrast agent for magnetic resonance imaging: initial clinical experience. Magn Res Imaging 3: 57-64, 1985.